Dr. Schondelmeyer is a professor at the University of Minnesota’s College of Pharmacy, where he holds the Century Mortar Club Endowed Chair in Pharmaceutical Management & Economics. He founded and serves as director of the PRIME Institute, which focuses on economic and public policy related to making pharmacists and medicines affordable and accessible to all. Schondelmeyer serves as the co-principal investigator of the Resilient Drug Supply Project. Following a B.S. in Pharmacy (1974) at the University of Missouri and a Doctor of Pharmacy (1977) and clinical residency (1974-1977) at the University of Kentucky, Schondelmeyer completed a Master in Public Administration (1979) and a Ph.D. in Administrative & Social Sciences in Pharmacy (1984) at the Ohio State University. He has served as a professor at the University of Arizona and Purdue University before his more than 30 years at the University of Minnesota.
For over 45 years, Schondelmeyer has conducted economic and policy analyses related to pharmacists, pharmaceuticals, and society. His insightful and credible research has influenced and shaped public policy, including passage of generic substitution laws and the development of drug formularies in the 1970s & 1980s, the emergence of managed care and PBMs in the 1980s, development of the Medicaid Drug Rebate program in the 1990s, the passage of the Medicare Part D program in the 2000s, the role of drug prices in affordability and accessibility of pharmaceuticals in the 2010s, and most recently the need to end drug shortages and to assure a resilient U.S. drug supply. He has testified before state, national, and international governmental bodies more than 150 times over the past few decades, including testimony more than 25 times before the U.S. Congress. He was appointed to serve Congress as a member of the Medicare Prescription Payment Review Commission (1988) and to serve as an advisor to several state Attorneys General.
Schondelmeyer has conducted more than 160 funded research studies, including projects with NIH, NSF, FDA, AHRQ, AHCPR, CMS, OTA, GAO, OIG, and ASPE. He has also received generous funding from major pharmacy professional associations and private foundations. He has published more than 400 research articles and reports on pharmacy practice, pharmaceutical economics, and public policy. His research has been published in pharmacy and public policy journals such as Health Affairs, Medical Care, Archives of Internal Medicine, New England Journal of Medicine, Health Services Research, American Journal of Public Health, Journal of Managed Care Pharmacy, and others. Schondelmeyer has given more than 900 invited presentations over the past 45 years and is recognized for insightful content and engaging delivery.
He has been a leader his whole career—from 1973-to 74 when he was the national President of the Student American Pharmaceutical Association, as a founding member of the International Society for Pharmaceutical Outcomes & Research (ISPOR), and while serving as Head of the University of Minnesota’s Department of Pharmaceutical Care & Health Systems for more than 20 years. Among his numerous awards are the Impact Award (1977) from his Pharm.D. peers at the University of Kentucky, the prestigious Paul F. Parker Lecture Award (2000), the APRS Research Achievement Award (2006), the Humphrey Award from APhA (2012) for public policy impact and service, the Tyler Prize for Stimulation of Research from APhA (2014), and the Leadership in Action Award (2016) from the Minnesota Health Action Coalition.
Schondelmeyer was born and raised in Sedalia, Missouri, is an Eagle Scout, and is a gentleman farmer of the 520 acres of land that have been in his family for more than 150 years. He was one of four children, is father of two, and now has five grandchildren.